MODULITE

Serial Number 76025013
Registration 2611432
710

Registration Progress

Application Filed
Apr 13, 2000
Under Examination
Feb 5, 2002
Approved for Publication
Oct 24, 2001
Published for Opposition
Nov 13, 2001
Registered
Aug 27, 2002

Basic Information

Serial Number
76025013
Registration Number
2611432
Filing Date
April 13, 2000
Registration Date
August 27, 2002
Published for Opposition
November 13, 2001
Cancellation Date
May 16, 2009
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
May 16, 2009

Rights Holder

CHIESI FARMACEUTICI S.P.A.

09
Address
Via Palermo 26/A
43100 PARMA
IT

Ownership History

CHIESI FARMACEUTICI S.P.A.

Original Applicant
09
43100 PARMA IT

CHIESI FARMACEUTICI S.P.A.

Owner at Publication
09
43100 PARMA IT

CHIESI FARMACEUTICI S.P.A.

Original Registrant
09
43100 PARMA IT

Legal Representation

Attorney
RICHARD P. BERG

USPTO Deadlines

Next Renewal Deadline
2607 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2002-08-27)
Due Date
August 27, 2032
Grace Period Ends
February 27, 2033

Application History

19 events
Date Code Type Description
May 16, 2009 C8.. O CANCELLED SEC. 8 (6-YR)
Aug 12, 2004 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
May 13, 2004 AMD7 I SEC 7 REQUEST FILED
Aug 11, 2003 COC. O CORRECTION UNDER SECTION 7 - PROCESSED
Jun 27, 2003 MAIL I PAPER RECEIVED
Aug 27, 2002 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 4, 2002 IUCN S NOTICE OF ALLOWANCE CANCELLED
Jul 4, 2002 1.BD I Sec. 1(B) CLAIM DELETED
Jun 3, 2002 MAIL I PAPER RECEIVED
Feb 5, 2002 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 13, 2001 PUBO A PUBLISHED FOR OPPOSITION
Oct 24, 2001 NPUB O NOTICE OF PUBLICATION
Jun 18, 2001 DOCK D ASSIGNED TO EXAMINER
Jun 18, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2001 DOCK D ASSIGNED TO EXAMINER
Feb 26, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2000 CNRT F NON-FINAL ACTION MAILED
Sep 15, 2000 DOCK D ASSIGNED TO EXAMINER

Additional Information

Other
In the statement, Column 1, Lines 5-9, "FOR: CHEMICAL AEROSOL COMPOSITIONS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS, NAMELY, FOR THE RELEASE OF MEDICATION INTO THE AIRWAYS, IN CLASS 1 (U.S. CLS. 1, 5, 6, 10, 26 AND 46)."
Other
In the statement, Column 1, line 7, before aerosol, " AN " should be inserted. In the statement, Column 2, line 2, "INFECTIOUS " should be deleted, and, " INFECTIONS" should be inserted. In the statement, Column 2, line 3 after, DISEASES, " , " should be deleted.
Pseudo Mark
MODULE LIGHT